Literature DB >> 19633478

Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer.

Jon-Paul J Voroney1, Andrew Hope, Max R Dahele, Thomas G Purdie, Thomas Purdy, Kevin N Franks, Shannon Pearson, John B C Cho, Alex Sun, David G Payne, Jean-Pierre Bissonnette, Andrea Bezjak, Anthony M Brade.   

Abstract

Stereotactic body radiotherapy is an emerging treatment option for peripheral non-small cell lung cancer in medically inoperable patients. With high dose per fraction radiotherapy, late side effects are of possible concern. In our initial cohort of 42 patients treated with 54 to 60 Gy in three fractions, nine patients have rib fracture. The median dose to rib fracture sites was 46 to 50 Gy, depending on the method of dose calculation. We describe a typical case of poststereotactic radiotherapy rib fracture and present dosimetric analysis of patients with rib fracture.

Entities:  

Mesh：

Year:  2009        PMID： 19633478     DOI： 10.1097/JTO.0b013e3181ae2962

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


  27 in total

Review 1.  Alternatives to surgery in early stage disease-stereotactic body radiotherapy.

Authors:  Meredith Elana Giuliani; Andrea Bezjak
Journal:  Transl Lung Cancer Res       Date:  2013-10

Review 2.  Are three doses of stereotactic ablative radiotherapy (SABR) more effective than 30 doses of conventional radiotherapy?

Authors:  Anna O Simeonova; Katharina Fleckenstein; Hansjörg Wertz; Anian Frauenfeld; Judit Boda-Heggemann; Frank Lohr; Frederik Wenz
Journal:  Transl Lung Cancer Res       Date:  2012-03

3.  Long-term loss of osteoclasts and unopposed cortical mineral apposition following limited field irradiation.

Authors:  Megan E Oest; Veerle Franken; Timothy Kuchera; Judy Strauss; Timothy A Damron
Journal:  J Orthop Res       Date:  2014-11-18       Impact factor: 3.494

4.  Stereotactic body radiotherapy for stage I non-small cell lung cancer.

Authors:  Ben J Slotman
Journal:  J Radiosurg SBRT       Date:  2011

5.  Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer.

Authors:  Robert W Mutter; Fan Liu; Andres Abreu; Ellen Yorke; Andrew Jackson; Kenneth E Rosenzweig
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-08-23       Impact factor: 7.038

6.  Bone scan findings of chest wall pain syndrome after stereotactic body radiation therapy: implications for the pathophysiology of the syndrome.

Authors:  Shane Lloyd; Roy H Decker; Suzanne B Evans
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

Review 7.  Role of stereotactic body radiotherapy in spinal metastasis and subsequent fracture risk: identifying and treating the at-risk patient.

Authors:  Mekhail Anwar; Igor J Barani
Journal:  CNS Oncol       Date:  2013-09

8.  Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity.

Authors:  Louise Murray; Ebru Karakaya; Samantha Hinsley; Mitchell Naisbitt; John Lilley; Michael Snee; Katy Clarke; Hima B Musunuru; Satiavani Ramasamy; Rob Turner; Kevin Franks
Journal:  Br J Radiol       Date:  2016       Impact factor: 3.039

9.  Parathyroid Hormone (1-34) Transiently Protects Against Radiation-Induced Bone Fragility.

Authors:  Megan E Oest; Kenneth A Mann; Nicholas D Zimmerman; Timothy A Damron
Journal:  Calcif Tissue Int       Date:  2016-02-04       Impact factor: 4.333

10.  Incidence of rib fractures after stereotactic body radiotherapy for peripheral lung lesions: clinical experience and dose response estimation.

Authors:  Wolfgang A Tomé; C Wesley Hodge; Minesh P Mehta; Søren M Bentzen
Journal:  J Radiosurg SBRT       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.